Brief: Medicinova Receives Notice Of Allowance For New Patent Covering Mn-166 (Ibudilast) For Treatment Of Als
13/12/2021 11:36
Dec 13 (Reuters) - MediciNova Inc MNOV.O :
* MEDICINOVA RECEIVES NOTICE OF ALLOWANCE FOR NEW PATENT
COVERING
MN-166 (IBUDILAST) FOR TREATMENT OF ALS
* MEDICINOVA INC- PATENT MATURING FROM ALLOWED PATENT
APPLICATION
IS EXPECTED TO EXPIRE NO EARLIER THAN NOV 2035
Source text for Eikon: ID:nGNXbgndfw
Further company coverage: MNOV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicinova
See all newsBrief: 3D Investment Partners Cuts Stake In Medicinova To 9.88% From 11.22%, Filing Shows
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX
MediciNova falls as fatty liver drug misses significance on blood-fat reduction
US STOCKS ON THE MOVE-WhiteHawk, Nvidia, Snowflake